Inhibition of IL-33 in Diabetic Kidney Disease: A Randomized, Placebo-Controlled Phase 2b Trial

Scritto il 21/01/2026
da Alexis Hofherr

No abstract

J Am Soc Nephrol. 2025 Dec 5. doi: 10.1681/ASN.0000000966. Online ahead of print.

NO ABSTRACT

PMID:41563367 | DOI:10.1681/ASN.0000000966